From: Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
Initial treatment | Number of survived mice | Group (see Fig. 4b) | Number of successful re-transplantations |
---|---|---|---|
L. monocytogenes-SMCC + R-848 + mannan-SMCC | 5 | b | 1 |
L. monocytogenes-SMCC + R-848 + poly(I:C) + mannan-SMCC | 5 | c | 0 |
R-848 + mannan-SMCC | 2 | d | 2 |
R-848 + poly(I:C) + mannan-SMCC | 1 | e | 0 |